AbbVie Inc - Stock Based Compensation

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Stock-Based-Compensation" stands at 1.47 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

AbbVie Inc's third quarter result of 0.209 Billion USD for the item "Stock Based Compensation" represents an increase of 16.76 percent compared to it's second quarter result.

Also, AbbVie Inc's third quarter result of 0.209 Billion USD for the item "Stock Based Compensation" represents an increase of 15.47 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of 1.47 Billion USD for the item "Stock Based Compensation" represents an increase of 1.94 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 68.81 percent compared to the value the year prior.
The 1 year change in percent is 68.81.
The 3 year change in percent is 120.36.
The 5 year change in percent is 111.49.
The 10 year change in percent is 441.18.

The Serie's long term average value is 0.522 Billion United States Dollars. It's latest available value, on 09/30/2025, is 181.79 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +803.20%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -0.742%.